Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chronic nightly dosing of lasmiditan for migraine prevention

Chronic nightly dosing of lasmiditan for migraine prevention

US Patent 12138254 · Granted Nov 12, 2024

Estimated economic value: $4,960,061,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rapid analgesia for skin puncture2008
Potentiators of glutamate receptors2004
Methods for identifying compounds for treating pain2004
Selective iGluR5 receptor antagonists for the treatment of migraine2003
Methods of treating or ameliorating the symptoms of common cold or allergic rhin2002
5-HT.sub.1F agonists intermediates1999
Methods of treating or ameliorating the symptoms of common cold or allergic rhin1999
Nitropyridine compound1999
Methods of treating or ameliorating the symptoms of venomous bites and stings1999
Method of treating or ameliorating the symptoms of common cold or allergic rhini1999
5-HT.sub.1F agonists1998
Serotonin agonist in combination with a tachykinin receptor antagonist in the tr1998